Related Experiment Video

Updated: May 31, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model

Charles S Via

    Clinical Immunology (Orlando, Fla.)
    |June 28, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance14:01

    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

    Published on: July 22, 2011

    Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis09:44

    Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

    Published on: October 14, 2025

    Related Concept Videos

    Preclinical Development: Overview01:28

    Preclinical Development: Overview

    Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...